Stockreport

Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Salt Lake City, UT, April 29, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, [Read more]